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Substantial toxicologic evidence suggests that
low-level exposure to organophosphate (OP)
pesticides affects neurodevelopment and
growth in developing animals (Chanda and
Pope 1996; Dam et al. 1998; Eskenazi et al.
1999; Gupta et al. 1985; Muto et al. 1992;
Schulz et al. 1995; Song et al. 1997; Whitney
et al. 1995). Recent biologic monitoring
studies, which include pregnant women and
children, show that there is widespread OP
pesticide exposure in the U.S. population
(Berkowitz et al. 2003; CDC 2003; Fenske et
al. 2000; Loewenherz et al. 1997; Lu et al.
2000; O’Rourke et al. 2000).
To address concerns about the potential
health effects of pre- and postnatal exposure of
children to pesticides, the Food Quality
Protection Act (FQPA) was passed in 1996,
signiﬁcantly amending the U.S. laws that regu-
late pesticides: the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA) and
the Federal Food, Drug, and Cosmetic Act.
The FQPA established a stringent health-based
standard (“a reasonable certainty of no harm”)
for pesticide residues in foods to assure protec-
tion from unacceptable pesticide exposure and
to strengthen health protections from pesticide
risks for sensitive populations. In addition,
the FQPA required the U.S. Environmental
Protection Agency (U.S. EPA) to consider the
cumulative effects on human health that may
result from exposure to mixtures of pesticides
(FQPA 1996). In response, the U.S. EPA
Ofﬁce of Pesticide Programs, in consultation
with the FIFRA scientiﬁc advisory panel, has
developed guidelines for the cumulative risk
assessment of pesticides that share a common
mechanism of toxicity (U.S. EPA 2002a,
2002d). The approach is conceptually similar
to methods developed by the U.S. EPA for
estimating exposures to mixtures of dioxins
and dibenzofurans using toxicity equivalence
factors to normalize the toxicity (i.e., binding
to the aryl hydrocarbon receptor) of each
member of the group with respect to that of a
single chemical (U.S. EPA 1989).
These new cumulative risk assessment
guidelines use the ﬁnding that OP pesticides
share a common mechanism of toxicity, the
inhibition of cholinesterase activity (Mileson
et al. 1998; U.S. EPA 1999a, 2001). The U.S.
EPA has determined oral benchmark dose10
(BMD10) values based on a 10% reduction in
brain cholinesterase activity compared to con-
trols for 33 OP pesticides (U.S. EPA 2002d).
These BMD10 values can be used to calculate
relative potency factors (RPFs) for cumulative
risk assessments of OP pesticide exposure.
RPFs are the ratio of the toxic potency of a
given chemical to that of an index chemical in
the cumulative assessment group. Thus, when
biologic measures of internal OP pesticide
dose are available, cumulative OP pesticide
dose equivalents can be calculated for a popu-
lation by converting individual OP pesticide
doses to index chemical toxicity equivalent
doses, using RPFs, and then summing them.
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Approximately 230,000 kg of organophosphate (OP) pesticides are applied annually in
California’s Salinas Valley. These activities have raised concerns about exposures to area residents.
We collected three spot urine samples from pregnant women (between 1999 and 2001) enrolled
in CHAMACOS (Center for the Health Assessment of Mothers and Children of Salinas), a longi-
tudinal birth cohort study, and analyzed them for six dialkyl phosphate metabolites. We used
urine from 446 pregnant women to estimate OP pesticide doses with two deterministic steady-
state modeling methods: method 1, which assumed the metabolites were attributable entirely to a
single diethyl or dimethyl OP pesticide; and method 2, which adapted U.S. Environmental
Protection Agency (U.S. EPA) draft guidelines for cumulative risk assessment to estimate dose
from a mixture of OP pesticides that share a common mechanism of toxicity. We used pesticide
use reporting data for the Salinas Valley to approximate the mixture to which the women were
exposed. Based on average OP pesticide dose estimates that assumed exposure to a single OP pes-
ticide (method 1), between 0% and 36.1% of study participants’ doses failed to attain a margin of
exposure (MOE) of 100 relative to the U.S. EPA oral benchmark dose10 (BMD10), depending on
the assumption made about the parent compound. These BMD10 values are doses expected to
produce a 10% reduction in brain cholinesterase activity compared with background response in
rats. Given the participants’ average cumulative OP pesticide dose estimates (method 2) and
regardless of the index chemical selected, we found that 14.8% of the doses failed to attain an
MOE of 100 relative to the BMD10 of the selected index. An uncertainty analysis of the pesticide
mixture parameter, which is extrapolated from pesticide application data for the study area and
not directly quantiﬁed for each individual, suggests that this point estimate could range from 1 to
34%. In future analyses, we will use pesticide-speciﬁc urinary metabolites, when available, to eval-
uate cumulative OP pesticide exposures. Key words: cumulative dose, exposure, mixtures,
organophosphate pesticides, pregnancy, prenatal, risk, urinary metabolites, women. Environ
Health Perspect 111:1640–1648 (2003). doi:10.1289/ehp.5887 available via http://dx.doi.org/
[Online 16 June 2003]
Children’s Health ArticleFenske et al. (2000) proposed that the
measurement of dialkyl phosphate metabolites
in children’s urine has utility for estimating
single OP pesticide dose ranges and thus can
provide information useful to discussions of
pesticide health risks. They reported that chil-
dren of farmworkers were more likely than
non-farmworker children to be exposed to the
OP pesticides azinphos-methyl and phosmet
at levels exceeding U.S. EPA chronic dietary
reference doses (RfDs).
Another vulnerable population is preg-
nant women and their fetuses. The present
study uses the proposed U.S. EPA cumula-
tive risk assessment guidelines (U.S. EPA
2002a, 2002d) to examine potential health
risks to pregnant women participating in
the CHAMACOS (Center for the Health
Assessment of Mothers and Children of
Salinas) study, a birth cohort study in an agri-
cultural area. All women assessed as part of the
CHAMACOS study had detectable levels of
urinary OP metabolites at some point in their
pregnancy, which are likely to be from a mix-
ture of compounds with varying toxicities and
use patterns (Figure 1). Recognizing that peo-
ple living in rural communities are potentially
exposed to mixtures of chemicals with varying
toxicities, this study seeks to expand the work
of Fenske et al. (2000) on children by evaluat-
ing pregnant women’s exposure to multiple
OP pesticides and assessing the cumulative
risk of these exposures. Our aim is to deter-
mine whether pregnant women living in this
region are potentially exposed to OP pesticides
in excess of a health-protective reference value.
Materials and Methods
Study area and population recruitment. The
Salinas Valley of Monterey County is an agri-
cultural area located in northern California, a
few kilometers from the Pacific Ocean. OP
insecticides are used on a variety of crops,
including lettuce, broccoli, cauliflower, and
strawberries. This region is approximately
25 km wide and 110 km long, extending from
Castroville in the north to King City in the
south. The temperate climate makes agricul-
tural production possible almost year-round.
This study is based on serial spot urine sam-
ples collected over 6 months from pregnant
women participating in the CHAMACOS
study, a prospective cohort study of children’s
environmental health. The CHAMACOS
study methods have been described previously
(Eskenazi et al. 2003). Pregnant women were
eligible for enrollment if they entered prenatal
care between September 1999 and November
2000 at either of two community clinics in the
area (Clinica de Salud del Valle de Salinas and
Natividad Medical Center). At enrollment, all
participants were at least 18 years of age, eligi-
ble for Medi-Cal health insurance, at less than
20 weeks’ gestation, fluent in English or
Spanish, and planning to deliver their child
at Natividad Medical Center. Medi-Cal is
California’s Medicaid health care program, and
eligibility is based on economic need. The
CHAMACOS study population is 94%
Mexican or Mexican American, with 96% of
participants living within 200% of the federal
poverty line (U.S. Bureau of the Census 2000).
Forty-four percent of study participants per-
formed field or other agricultural work after
becoming pregnant, and 87% lived in house-
holds where at least one adult member worked
in agriculture.
Informed consent was obtained from all
study participants following procedures estab-
lished by the institutional review boards at the
University of California, Berkeley, and the
Natividad Medical Center. Maternal body
weight and fetal gestational age data were
abstracted from study participants’ medical
records.
Urine collection, storage, and analysis. We
collected urine samples from women twice dur-
ing pregnancy, at approximately 14 weeks ges-
tation (n = 593) and approximately 26 weeks
gestation (n = 500), and after delivery (n =
493). All three urine samples were collected
from 460 women. Specimens were stored at
–80°C until shipment to the Centers for
Disease Control and Prevention, where six non-
speciﬁc urinary OP metabolites were measured:
dimethylphosphate (DMP), dimethyldithio-
phosphate (DMDTP), dimethylthiophosphate
(DMTP), diethylphosphate (DEP), diethyl-
dithiophosphate (DEDTP), and diethylthio-
phosphate (DETP). These metabolites derive
from approximately 40 OP compounds, 28 of
which are registered with the U.S. EPA for use
in the United States, falling into the general
categories of dimethyl and diethyl OP pesti-
cides (Table 1).
The laboratory methods for dialkyl phos-
phate quantification employed the isotope
dilution technique combined with gas chro-
matography and mass spectrometry (Bravo et
al. 2002). Isotope dilution is widely regarded
as the state-of-the-art technique for trace
analysis with dialkyl phosphate metabolite
detection limits of 1 ppb or less (Barr et al.
1999). Creatinine concentrations in urine were
determined using a commercially available diag-
nostic enzyme method (Vitros CREA slides;
Ortho Clinical Diagnostics, Raritan, NJ).
Laboratory quality control (QC) was estab-
lished by the repeat analysis of two in-house
urine pools enriched with known amounts of
pesticide residues whose target values and con-
ﬁdence limits were previously determined. An
analytical run was considered “out of control”
if the QC value failed to meet the requirements
of the Westgard QC multirules (Westgard
2002). Data were not reported from runs
considered “out of control.”
Data analysis. We statistically analyzed
urinary metabolite data from only the women
who provided three urine samples. We used
the following reporting convention for the six
dialkyl phosphate metabolites: Samples with
no analytical response were considered nonde-
tectable and were assigned a value of zero;
samples with a detectable peak were reported
as numerical values in micrograms per liter of
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Figure 1. Relative hazard of agricultural OP pesticide use in the Salinas Valley. This chart allows compari-
son of the relative hazard of OP pesticides used in the Salinas Valley, weighted by pesticide use (DPR
2000) and toxicity (BMD10). For example, total use of malathion is greater than that of oxydemeton-methyl
(DPR 2000); however, because oxydemeton-methyl is a much more potent inhibitor of cholinesterase (i.e.,
malathion oral BMD10 = 313.9 mg/kg/day vs. oxydemeton-methyl BMD10 = 0.09 mg/kg/day), its potential
hazard is much higher.
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assess the correlation of the urinary diethyl
and dimethyl phosphate molar concentrations
between the different sampling points. The
creatinine concentration in each urine sample
was reported as milligrams of creatinine per
deciliter of urine. One participant with miss-
ing creatinine concentration data and four
participants with urinary creatinine levels that
implied unreasonably high ﬂuid consumption
rates (< 10 mg/dL) were excluded from our
ﬁnal analyses. Two participants with missing
body weight data and seven participants who
provided urine samples more than 60 days
after delivery were also excluded, leaving a
ﬁnal sample size of 446 women.
Pesticide use data. In California, all agri-
cultural pesticide use is reported to the county
agricultural commissioner, who then reports it
to the California Department of Pesticide
Regulation (DPR; Sacramento, CA). For agri-
cultural use, crop, active ingredient, date,
pounds applied, and the location of use, iden-
tified to a one-mile (1.6 km) square section,
are reported. We obtained the pesticide use
report (PUR) data sets for 1999, 2000, and
2001 from the DPR. To define agricultural
OP pesticide use in the Salinas Valley, we
selected all 1-mile (1.6 km) sections within a
200-foot (61-m) elevation contour from the
Salinas River with reported pesticide use.
Ninety-nine percent of CHAMACOS partici-
pants lived within this area. Other pesticide
uses, including for landscape (i.e., golf courses,
parks, cemeteries), structural, and right-of-way
purposes, are reported by month and are not
geographically identiﬁed (reported at county
level only). These nonagricultural uses
accounted for 0.8%, 1.0%, and 1.1% of
Monterey County OP pesticide use for 1999,
2000, and 2001, respectively. We accounted
for these other uses in our weekly and annual
summaries of all 1999, 2000, and 2001 OP
pesticide applications in the region as follows:
To describe annual use, they were simply
added to the total; for weekly use, monthly
instances of these nonagricultural uses were
divided by four and added to the agriculture
use information.
The PUR data we used for dose estimation
were concurrent with the year in which urine
samples were collected. Two factors support
our choice to use annual data to represent the
mixtures, rather than daily, weekly, monthly,
or other time periods more proximate to the
urine collection. First, the annual PUR data
are more likely to approximate mixtures across
all sources and times. Second, mapping of
PUR data in the Salinas Valley reveals that
pesticide use is relatively uniform and that
there are no apparent “hot spots.”
Dose calculations. We used two methods
to estimate OP pesticide doses from the uri-
nary metabolite concentration data. For
method 1, we assumed that metabolite levels
were the result of exposure to a single pesti-
cide (Fenske et al. 2000). For method 2, we
assumed that observed metabolites were
attributable to exposure to a mixture of OP
pesticides that share a common mechanism of
toxicity and similar dose–response curves
(U.S. EPA 2001, 2002b, 2002d).
Underlying our dose estimation models
are the following assumptions: a) Urinary
concentrations represent steady-state condi-
tions over a 24-hr period. Under this steady-
state assumption, we estimated a full day’s
urinary excretion of metabolites based on a
spot urine sample using creatinine as an index
of total daily urinary output volume. The
relationship between 24-hr urine output vol-
ume and urinary creatinine is given by the
following formula:
[1]
where Vi is the expected 24-hr urine output
volume for the ith pregnant woman (liters per
day), Ccri is the reference value for the ith
pregnant woman’s daily creatinine excretion
(milligrams per day) (Davison et al. 1980;
Davison and Noble 1981; Knuppel et al.
1979), and Cci is the creatinine concentration
in the ith woman’s urine sample (milligrams
per liter).
b) All (100%) of absorbed maternal OP
pesticide dose is expressed in urine as diethyl
and dimethyl phosphate metabolites.
c) The parent compounds of the six uri-
nary OP metabolites depend strongly on the
mixture of OP pesticides used for agriculture,
structural pest control, right-of-way, or land-
scape purposes in the Salinas Valley. That is
to say, the proportion of chemicals applied is
a reasonable surrogate for the mixture of OP
pesticides to which the women were exposed
from all sources.
d) OP metabolite concentrations are
equivalent to internal doses on a molar basis.
Because each OP pesticide molecule devolves
into exactly one of its possible dialkyl phos-
phate metabolites, the molar sum of metabo-
lite equals the molar concentration of OP
pesticide.
Method 1: single chemical approach. We
calculated single dose estimates assuming
100% of the exposure was from a single
diethyl or dimethyl OP pesticide. We
assumed that urinary diethyl phosphate
metabolites were attributable to chlorpyrifos,
diazinon, or disulfoton and that dimethyl
phosphate metabolites were attributable to
dimethoate, malathion, methidathion, naled,
or oxydemeton-methyl. These OP com-
pounds are consistently among the most
heavily used pesticides in the Salinas Valley
(i.e., they account for 100% and 99% of total
diethyl and dimethyl OP pesticide use,
respectively), according to the California
DPR’s PUR (DPR 1999, 2000). Dose esti-
mates were not aggregated across diethyl and
dimethyl OP pesticide classes. Only the rele-
vant metabolites for each compound were
considered in the dose calculations; for exam-
ple, chlorpyrifos dose calculations were based
   Vii i = Ccr Cc
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Table 1. OP pesticide usage in the Salinas Valleya,b and associated urinary dialkyl phosphate metabolites, oral BMD10 values, and RPFs for cumulative assessment
group.
1999 2000 2001
Kilograms Percent Kilograms Percent Kilograms Percent BMD10
Pesticidec applied applied applied applied applied applied (mg/kg/day) RPFd Metabolites
Azinphos-methyl 626 0.6 101 0.1 56 0.1 0.86 1.72 DMP, DMTP, DMDTP
Dimethoate 19,232 18.4 16,115 15.1 15,523 15.3 0.25 5.92 DMP, DMTP, DMDTP
Malathion 35,188 33.6 45,727 42.8 44,181 43.5 313.91 0.005 DMP, DMTP, DMDTP
Methidathion 6,779 6.5 6,926 6.5 6,449 6.3 0.25 5.92 DMP, DMTP, DMDTP
Methyl parathion 66 0.1 0 0.0 0 0.0 0.67 2.21 DMP, DMTP
Naled 11,979 11.4 9,315 8.7 7,749 7.6 1.00 1.48 DMP
Oxydemeton-methyl 30,028 28.7 27,759 26.0 26,244 25.8 0.09 16.44 DMP, DMTP
Phosmet 743 0.7 909 0.9 1,436 1.4 3.56 0.42 DMP, DMTP, DMDTP
Total dimethyls 104,640 100.0 106,852 100.0 101,638 100.0
Chlorpyrifos 29,423 34.6 27,325 30.4 25,283 27.5 1.48 1.00 DEP, DETP
Diazinon 47,847 56.4 56,883 63.2 61,944 67.4 6.24 0.24 DEP, DETP
Disulfoton 7,613 9.0 5,763 6.4 4,634 5.1 0.07 21.14 DEP, DETP, DEDTP
Total diethyls 84,883 100.0 89,971 100.0 91,861 100.0
aIncludes agricultural, landscape maintenance, structural pest control, and right-of-way pesticide use (DPR 1999, 2000, 2001). bPesticide use is reported in kilograms of active ingredient.
cOP pesticides that do not metabolize to dialkyl phosphate compounds (e.g., bensulide, acephate) are not listed. dBy deﬁnition, the RPF for the index chemical, chlorpyrifos, is 1.Environmental Health Perspectives • VOLUME 111 | NUMBER 13 | October 2003 1643
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upon DEP and DETP concentrations only
(Table 1). This method provides a reasonable
upper-bound estimate of dose from exposure
to speciﬁc chemicals, and it is consistent with
current regulatory methods.
Dose estimates from single diethyl and
dimethyl OP pesticides were calculated with
the following equations:
For diethyls,
[2]
For dimethyls,
[3]
where DDiethyl is the dose from diethyl OP pes-
ticide (micrograms per kilogram per day),
DDimethyl is the dose from dimethyl OP pesti-
cide (micrograms per kilogram per day), C is
the urinary dialkyl phosphate metabolite con-
centration (micrograms per liter), MWDiMet_OP
is the molecular weight of a dimethyl OP
pesticide (grams per mole), MWDiEt_OP is the
molecular weight of a diethyl OP pesticide
(grams per mole), CrEx is the expected daily
urinary creatinine excretion (milligrams per
day) from reference values for pregnant
women (Davison and Noble 1981; Davison
et al. 1980; Knuppel et al 1979), CrConc is the
creatinine concentration (milligrams per liter)
derived from urine samples, and BW is the
pregnant woman’s body weight (kilograms)
around the time of urine sample collection.
Reported average doses are the arithmetic
means of three single-day dose estimates (creati-
nine adjusted) based on urine samples collected
from participants twice during pregnancy and
once postpartum.
Method 1: risk estimation. We used the
U.S. EPA BMD10 as the basis for our risk
estimates. This BMD10 has been developed
for ingestion of OP pesticides and is based on
dose–response data for brain cholinesterase
inhibition in female rats representing a 10%
change in enzyme levels compared with
controls, derived from laboratory studies that
lasted 21 days or longer (U.S. EPA 2002a,
2002b, 2002d). Current U.S. EPA oral
BMD10 values for the OP pesticides used in
the Salinas Valley range from 0.07 to 313.9
mg/kg/day (Table 1) (U.S. EPA 2002d). The
BMD is the dose that corresponds to a speci-
fied level of increased response (the bench-
mark response) compared with background.
This dose is calculated by ﬁtting a mathemati-
cal model to the dose–response data.
The U.S. EPA is developing BMDs as an
alternative to the no-observable-adverse-effect
level (NOAEL) and lowest-observable-
adverse-effect level as points of departure for
deriving RfDs for noncancer risk assessments
because they use all points on the dose–
response curve, are less sensitive to the num-
ber of animals used in a study, and do not
depend on dose spacing. The hazard quotient,
deﬁned as the ratio of an observed dose to an
RfD, is used to express risk relative to an
RfD. In contrast to the hazard quotient, the
U.S. EPA uses a margin of exposure (MOE),
the ratio of a point of departure (i.e., BMD)
to an observed dose, to express risk using the
BMD. Although an acceptable hazard quo-
tient should be less than 1, an acceptable
MOE should be signiﬁcantly greater than 1,
typically 100 or more, depending on the
health end point and the quality and source
of data used to obtain the BMD.
We selected a health-protective dose for
our population based on the U.S. EPA oral
BMD10 and an MOE of 100. Thus, the dose
exceeding the BMD10 divided by 100 is a dose
of concern. We selected the BMD10 as the
point of departure for this analysis, and used
an MOE of 100 to account for animal to
human extrapolation and intrahuman variabil-
ity. The point of departure is meant to repre-
sent the lowest dose with a speciﬁed response
within the range of experimental data. Risk
associated with lower, environmentally rele-
vant human exposures can be extrapolated
from the point of departure. Using doses
exceeding the BMD10/100 as doses of concern
permits direct comparison of our method 1
and method 2 risk estimate results.
The BMD10 is an appropriate measure of
toxic potency for cumulative risk assessments
of OP pesticides because it represents the
common end point and mechanism of action
for the cumulative assessment group. The
acute and chronic U.S. EPA RfDs for individ-
ual OP pesticides, however, are based on
NOAELs found for the most sensitive end
point in the most sensitive species. These
RfDs and NOAELs were derived for use in
single chemical assessments, and thus are not
recommended for use in cumulative assess-
ments because they may not toxicologically
represent the common mechanism of action
(U.S. EPA 2002a).
Method 2: chemical mixture approach. An
obvious limitation to method 1 is that women
are probably exposed to the mixture of pesti-
cides in their environment, rather than to a sin-
gle compound. To estimate cumulative dose
from exposure to mixtures of OP pesticides, we
converted each relevant pesticide into its index
chemical toxicity equivalent using RPFs, which
are the ratio of the toxic potency of a given
chemical to that of an index chemical in the
cumulative assessment group. We used U.S.
EPA oral BMD10 values for brain cholinesterase
inhibition as the measure of potency in our
RPF calculations, and we selected chlorpyrifos
as the index compound (Table 1) (U.S. EPA
2002d). A complete description of the methods
and rationale for this process can be found in
the U.S. EPA cumulative risk assessment
reports (U.S. EPA 2001, 2002a, 2002b,
2002d). As deﬁned by the U.S. EPA,
[4]
where chemical n is a member of the cumula-
tive assessment group, index chemical is the
chemical selected as the basis for standardiza-
tion of toxicity of components in a mixture,
and measure of potency is the BMD10.
The pesticides in our cumulative assessment
group are the 11 (3 diethyl and 8 dimethyl) OP
pesticides commonly applied in the Salinas
Valley that metabolize to dialkyl phosphate
compounds (Table 1). PUR data for this
region were used to describe the likely mixture
to which the women were exposed. We
selected chlorpyrifos as the index chemical
because a) it is a compound in our cumulative
assessment group for which complete hazard
assessment and dose–response information is
available, b) it metabolizes into urinary dialkyl
phosphate compounds, c) it is commonly used
in the Salinas Valley (DPR 1999, 2000), and
d) its measure of relative toxicity, as expressed
by the BMD10, falls in the mid-range of
BMD10 values for the OP pesticides in our
cumulative assessment group. Method 2 risk
estimates based on cumulative dose equivalents
are insensitive to the choice of index chemical.
Using RPFs, we calculated a pregnant woman’s
cumulative OP pesticide dose equivalent with
the following equation:
[5]
where DCum is the cumulative dose equivalent
(micrograms per kilogram per day), µMolDiethyl
is total micromoles of diethyl phosphate metab-
olites (DEP, DETP, DEDTP) excreted over a
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  ÷24-hr period (see Equation 1), µMolDimethyl is
total micromoles of dimethyl phosphate
metabolites (DMP, DMTP, DMDTP)
excreted over a 24-hr period (see Equation 1),
Pi is the proportion of pesticide i in the mix-
ture calculated from annual PUR data for the
Salinas Valley, MWi is the molecular weight of
the ith pesticide (micrograms per micromole),
RPFi is the relative potency factor of the ith
pesticide in the cumulative assessment group,
and BW is the pregnant woman’s body weight
(kilograms) around the time of urine sample
collection.
To estimate three single-day cumulative
dose equivalents (creatinine-adjusted), we used
measured metabolite levels in the three urine
samples obtained from all study participants.
We then calculated the arithmetic mean and
summarized the minimum, median, and maxi-
mum dose equivalent from these estimates. For
comparison with creatinine-adjusted estimates,
we calculated volume-adjusted cumulative dose
equivalents using reference values for pregnant
women’s total daily urine output volume
(Cohen 2000; Davison and Noble 1981).
Method 2: uncertainty analysis. The
parameter deﬁning the mixture of OP pesti-
cides to which study participants were poten-
tially exposed is a key source of uncertainty in
our assessment. To evaluate the sensitivity of
the model to this parameter, we used Monte
Carlo simulation software (Crystal Ball
Standard Edition 2000; Decisioneering, Inc.,
Denver, CO) to vary the quantity of pesti-
cides used to describe the assumed exposure
mixture. We ran 5,000 simulations based on
uniform sampling distributions of the weekly
kilograms of pesticides applied in the
CHAMACOS study area from 1999 through
2001 (DPR 1999, 2000, 2001). The uniform
distributions were bounded by zero and by
110% of each pesticide’s maximum reported
weekly quantity applied.
Method 2: cumulative risk estimation.
To assess risk we compared estimated mini-
mum, average, and maximum cumulative dose
equivalents with an MOE of 100 relative to
the index chemical’s BMD10 (for chlorpyrifos,
this value is BMD10/100 = 14.8 µg/kg/day).
Our intent is to imply that women with
cumulative dose equivalents that exceed the
index chemical’s BMD10/100 are potentially
affected. Thus, our concept of risk is the frac-
tion of the study population with cumulative
OP pesticide dose estimates above what we
consider a health-protective dose (the index
chemical’s BMD10/100).
We calculated MOEs by taking the ratio of
the point of departure, chlorpyrifos’s BMD10,
to the estimated minimum, average, and maxi-
mum single-day cumulative dose equivalents
(Figure 2). The MOE is speciﬁcally identiﬁed
by the U.S. EPA Ofﬁce of Pesticide Programs
as an appropriate metric for characterizing risk
from exposure to mixtures of OP pesticides
(U.S. EPA 2002b).
Results
Urine samples were collected from pregnant
women at two prenatal study visits (around 14
and 26 weeks’ gestation) and after delivery; all
three samples were obtained from 460 women.
Summary statistics of the urinary OP metabo-
lites for our final sample of 446 women are
presented in Table 2. Forty-two of 1,338 sam-
ples (3%) had no measurable metabolites, and
we set concentrations for the six metabolites
equal to zero. Among the dimethyl phosphate
metabolites, the median concentrations were
DMP, 1.7 µg/L; DMTP, 6.3 µg/L; and
DMDTP, 0.5 µg/L. Among the diethyl phos-
phate metabolites, the median concentrations
were DEP, 1.1 µg/L; DETP, 0.9 µg/L; and
DEDTP, 0 µg/L. Overall, the dimethyl phos-
phate levels were higher than diethyl phosphate
levels (Table 2).
Dose calculations. Method 1: single chem-
ical approach. Table 3 summarizes the results
for the single OP pesticide dose calculations
(n = 446), including geometric mean, median,
and range, for this study population. We pre-
sent average dose estimates calculated by taking
the arithmetic mean of three single-day doses.
Depending on the assumption made about the
parent compound, creatinine-adjusted average
dose estimates ranged from 0 to 45.7 µg/kg/day.
Median dimethyl OP pesticide dose estimates
ranged from 0.18 to 0.92 µg/kg/day, and
median diethyl OP pesticide dose estimates
ranged from 0.12 to 0.15 µg/kg/day.
Method 1: risk estimation. Depending on
the choice of pesticide used in the dose calcu-
lation, we found that between 0 and 36.1% of
participants had dose estimates that exceed
0.01 times the U.S. EPA BMD10 value, which
corresponds to an MOE of 100 relative to the
BMD10 (Table 3). The large variability under-
scores the signiﬁcance of the assumption made
about which OP parent compound is respon-
sible for the exposure. The results suggest,
however, that a portion of pregnant women
participating in the CHAMACOS study may
have exposures exceeding a health-protective
MOE for individual OP pesticides.
Method 2: chemical mixture approach.
Table 4 presents summary statistics for aver-
age cumulative OP pesticide dose equivalents
derived from three spot urine samples. These
dose estimates are log-normally distributed
and range from 0.1 to 171.4 µg/kg/day
(cumulative dose equivalents). Estimated dose
equivalents from only the dimethyl OP pesti-
cides ranged from 0.1 to 171.3 µg/kg/day,
and estimated dose equivalents from only the
diethyl OP pesticides ranged from 0.01 to 6.6
µg/kg/day. All study participants had average
cumulative dose equivalent estimates greater
than zero, and the geometric mean cumula-
tive dose equivalent estimate for this popula-
tion was 4.5 [95% conﬁdence interval (95%
CI), 4.1–5.1] µg/kg/day (Table 4). Maximum
single-day cumulative dose equivalent esti-
mates ranged from 0.3 to 507.2 µg/kg/day
[geometric mean = 9.0 (95% CI, 8.0–10.1)
µg/kg/day]. Minimum and median single-day
cumulative dose equivalent estimates ranged
from 0 to 20.6 µg/kg/day [geometric mean =
0.7 (95% CI, 0.6–0.8) µg/kg/day] and from 0
to 32.3 [geometric mean = 2.5 (95% CI,
2.2–2.7) µg/kg/day], respectively.
Spearman rank correlation analyses indi-
cate little or no correlation between the uri-
nary metabolite levels at the three different
sampling times. Spearman R values ranged
from 0.04 to 0.11. The highest correlation
coefficient (R = 0.11), found between the
dimethyl phosphate metabolite concentra-
tions in samples collected at ~14 weeks and
~26 weeks gestation, was statistically signifi-
cant because of the large sample size (p =
0.02) but was low in magnitude. The average
of the ranges in the women’s urinary dialkyl
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Figure 2. MOEs for estimated maximum, average, and minimum cumulative dose equivalents for pregnant
women (n = 446).
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cumulative dose equivalentsphosphate metabolite levels was 0.02 mg/L
(SD = 0.05 mg/L). Because urine samples were
variable and uncorrelated between sampling
periods, we present the women’s estimated
minimum and maximum single-day cumula-
tive dose equivalents in addition to their average
cumulative dose equivalent (Figure 2).
For comparison with these creatinine-
adjusted estimates, we also generated cumula-
tive dose equivalent estimates by adjusting for
total daily urine volume based on reference
values for pregnant women (Cohen 2000;
Davison and Noble 1981). Cumulative dose
equivalents calculated from volume-adjusted
data were highly correlated with creatinine-
adjusted estimates (R2 = 0.8), and results were
very similar (data not shown). The geometric
mean and median volume-adjusted estimates
were slightly higher than creatinine-adjusted
estimates, and the percentage of pregnant
women with average cumulative dose equiva-
lents that exceeded the index chemical’s
BMD10/100 was also higher (15.9 vs. 14.8%).
Method 2: cumulative risk estimation.
Figure 3 presents the distribution of average
cumulative dose for the entire population in
index chemical (chlorpyrifos) toxicity equiva-
lents (micrograms per kilogram per day). We
found that 14.8% of estimated cumulative
dose equivalents exceeded the index chemical’s
BMD10 divided by a 100-fold uncertainty
factor (14.8 µg/kg/day). The percentages of
pregnant women exceeding this health-
protective dose from exposure to only the
dimethyl OP pesticides or only the diethyl
OP pesticides were 14.1 and 0%, respectively
(Table 4). No participant had a cumulative
dose equivalent estimate exceeding the chlor-
pyrifos point of departure (an oral BMD10 of
1,480 µg/kg/day).
We performed additional analyses to inves-
tigate the impact of the maximum single-day
cumulative dose estimate on our average
cumulative dose estimates. We found that
30% of the 66 women with average cumulative
dose estimates exceeding the index chemical’s
BMD10/100 had two or more single-day esti-
mates that were greater than the BMD10/100.
Therefore, the average cumulative dose esti-
mates could have been shifted upward by the
maximum single-day high values, if they were
rare events. Extending this analysis to the
entire study population, we found that 26 of
446 (5.8%) women had two or more single-
day estimates greater than the index chemical’s
BMD10/100. The geometric mean of the esti-
mated cumulative dose equivalents for this
group (22.6 µg/kg/day; 95% CI, 18.8–27.1)
exceeded the index chemical’s BMD10/100
(14.8 µg/kg/day). Further, we found that 126
of 446 (28.3%) women had one single-day
estimate and 294 of 446 (65.9%) women had
no single-day estimate greater than the index
chemical’s BMD10/100.
We calculated MOEs for the estimated
minimum, average, and maximum single-day
cumulative dose equivalents. Figure 2 presents
a range of MOEs at various percentiles on a
logarithmic scale. An estimated 0.4, 14.8, and
34.0% of calculated margins of exposure were
less than 100 for women’s minimum, average,
and maximum cumulative doses, respectively.
An MOE of less than 100 implies that the
estimated cumulative dose is greater than the
point of departure divided by a 100-fold
uncertainty factor (e.g., index chemical’s
BMD10/100).
The U.S. EPA is developing guidelines for
formally incorporating standard uncertainty
factors and FQPA safety factors into cumula-
tive risk assessment for OP pesticides (U.S.
EPA 2002c). Final consideration of the FQPA
safety factor is pending (U.S. EPA 2002d).
Method 2: uncertainty analysis. Based on
5,000 simulations, the estimated average
cumulative chlorpyrifos dose equivalents
ranged from 0.03 to 314.9 µg/kg/day, and the
population median ranged from 1.3 to 8.7
(mean = 4.3) µg/kg/day. The percentage of
participants with estimated average cumulative
dose equivalents exceeding the BMD10/100 of
chlorpyrifos ranged from 1 to 34% (mean =
14%), and the 10th and 90th percentiles were
8 and 23%, respectively. Although the simula-
tions produced dose estimates that varied sub-
stantially, the simulation averages were
consistent with the method 2 point estimates
presented in Table 4.
Method 1 and 2 comparisons. As expected,
the method 2 average risk estimate fell between
the upper and lower risk estimates from
method 1. When assessing exposure to a single
pesticide (method 1), we attributed all diethyl
or dimethyl OP pesticide dose to a particular
compound. Because the chemicals in our
cumulative assessment group have varying toxi-
cities, when we estimate the number of people
potentially exposed over the health-protective
dose using method 1, we have estimates that
range from the least to the greatest number
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Table 2. Urinary dialkyl phosphate metabolite and creatinine levels, method limits of detection (µg/L), and
percentage of samples assigned a value of zero for 1,338 urine samples collected from 446 women.a
Percentiles Mean Percent Percent
Analyteb Range 10thc 25thc 50th 75th 90th LODd < LOD zero value
DMP 0–2,754 0 0 1.7 6.2 16.7 0.7 37.2 25.5
DMTP 0–2,922 0 1.3 6.3 19.6 52.8 0.5 17.0 12.8
DMDTP 0–540 0 0 0.5 3.1 13.2 0.3 46.8 43.0
DEP 0–160 0 0 1.1 4.1 9.5 0.3 40.1 29.1
DETP 0–101 0 0 0.9 2.5 5.8 0.2 29.7 26.6
DEDTP 0–44 0 0 0 0.2 0.6 0.1 71.4 51.5
Creatinine 11.2–461.4 34.8 53.8 88.2 129.5 176.1 5.0 0 0
aThree samples each. bDMDTP had six missing values; DMP and DEP had two missing values; DETP had one missing
value (i.e., no result reported because of an unknown analytical interference in the urine sample). c0 = No instrument
response. dMean limits of detection (LOD) derived from multiple batches of urine samples.
Table 3. Method 1 average OP pesticide dose estimates for pregnant women (n = 446) based on CHAMACOS data relative to U.S. EPA BMD10 values divided by a
100-fold uncertainty factor (µg/kg/day).a,b
Dimethyl OP pesticidesc Diethyl OP pesticides
Dimethoate Malathion Methidathion Naled Oxydemeton-methyl Chlorpyrifos Diazinon Disulfoton
10th percentile 0.14 0.20 0.18 0.02 0.12 0.04 0.04 0.04
25th percentile 0.31 0.44 0.41 0.07 0.27 0.08 0.07 0.06
50th percentile 0.64 0.92 0.84 0.18 0.57 0.15 0.13 0.12
75th percentile 1.50 2.16 1.97 0.48 1.34 0.28 0.24 0.23
90th percentile 3.14 4.52 4.14 1.08 3.00 0.48 0.42 0.40
Geometric mean 0.66 0.94 0.86 0.18 0.58 0.15 0.13 0.12
(95% CI) (0.58–0.74) (0.84–1.06) (0.77–0.97) (0.16–0.21) (0.52–0.66) (0.13–0.16) (0.12–0.14) (0.11–0.13)
Range 0.02–27.81 0.02–40.07 0.02–36.67 0–45.67 0.01–29.86 0–4.36 0–3.78 0–3.45
BMD10/100 (µg/kg/day)d 2.5 3139.1 2.5 10.0 0.9 14.8 62.4 0.7
Estimates exceeding BMD10/100 (%) 57 (12.8) 0 (0) 83 (18.6) 3 (0.7) 161 (36.1) 0 (0) 0 (0) 21 (4.7)
U.S. EPA chronic RfD (µg/kg/day)e 0.5 24 1.5 2 0.125 0.3 0.2 0.13
aMethod 1 assumes 100% of OP pesticide dose is from single dimethyl or diethyl OP pesticide. bAverage dose estimates were derived from metabolite levels measured in three urine
samples. cDose estimates for three dimethyl OP pesticides with use < 2,000 kg/yr (i.e., azinphos-methyl, phosmet, and methyl parathion) are not presented. dHealth-protective dose level:
oral BMD10/100. eU.S. EPA oral RfD (U.S. EPA 1999b, 1999c, 1999d, 1999e, 2000a, 2000b, 2000c, 2000d).
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group and the observed metabolite levels. Any
mixture will have a cumulative toxicity, and
consequently a risk level, somewhere between
these two end points.
Discussion
We estimated OP pesticide doses based on uri-
nary OP metabolite levels using two methods.
The first assumed exposure to a single pesti-
cide; the second assumed exposure to a mixture
of OP pesticides. We found that average
cumulative dose equivalents for 14.8% of
CHAMACOS study participants were below
the MOE of 100, which was used to deﬁne a
dose of concern. Our uncertainty analysis of
the pesticide mixture parameter suggests that
this point estimate could range from 1 to 34%.
This report presents one of the first case
studies using the U.S. EPA’s new cumulative
risk assessment framework for OP pesticides.
Current U.S. EPA guidelines provide a
methodology for calculating cumulative dose
using traditional exposure assessment meth-
ods that track exposure from source to dose
(U.S. EPA 2002a, 2002b, 2002d). Such
models rely on source-speciﬁc environmental
concentration data, behavioral factors, and
route-specific absorption factors. We used
only the portions of the guidelines dealing
with dose aggregation because our dose esti-
mations are based on biomonitoring data.
We used U.S. EPA BMD10 values as the
measure of toxic potency to calculate OP pesti-
cide RPFs. These BMD10 values were derived
from dose–response curves from studies of
brain cholinesterase inhibition in female rats
(U.S. EPA 2002b). With the use of these
methods, cumulative dose estimates, which are
toxicologically equivalent to a dose of the index
chemical, will vary depending on the choice of
the index chemical. The risk estimates based
on these doses, however, will remain consistent
regardless of the index chemical chosen from
our cumulative assessment group.
Both methods of dose calculation pre-
sented here introduce uncertainty due to the
assumption of parent compound(s), use of cre-
atinine to estimate 24-hr urinary metabolite
excretion, and intraindividual and temporal
variability. Because our assessment was based
on nonspeciﬁc metabolite data, it was necessary
to make assumptions about the mixture of pes-
ticides to which each participant was exposed
(i.e., the presence of urinary dialkyl phosphate
metabolites indicates exposure to one or more
OP pesticides but does not indicate exposure
to any particular pesticide). We incorporated
PUR data for the Salinas Valley into cumula-
tive dose equivalent calculation models to
quantify the assumed mixture of parent com-
pounds that resulted in an individual’s urinary
OP metabolites levels.
A limitation to this analysis is our assump-
tion that the mixture of pesticides applied in
the region for agricultural, landscaping, struc-
tural pest control, or right-of-way purposes is
proportional to the mixture of OP pesticides
to which the women were exposed. For indi-
viduals living in rural areas, there are other
sources of pesticide exposure in addition to
regional pesticide applications, including diet
and home pesticide use. On the basis of home
visit inspections conducted during pregnancy,
we found that only 7% of women stored OP
pesticides in their homes and that the presence
of these pesticides was not statistically corre-
lated with urinary metabolite levels. In addi-
tion, OP pesticide residues found in the
participants’ house dust included compounds
that are used exclusively for agriculture (e.g.,
oxydemeton-methyl was detected in 67% of
homes). Residues of malathion, diazinon, or
chlorpyrifos were found in 93% of homes,
even though these compounds were identiﬁed
as pesticides used in or around only 6% of
homes (Bradman A. Unpublished data).
More broadly, we are assuming that the
proportions of chemicals applied in the study
area were a reasonable surrogate for the mix-
ture of pesticides to which the women were
exposed from all sources, including those that
do not originate in the Salinas Valley. Some
assumption about mixture is necessary for this
analysis, and we believe that what we have
proposed is a reasonable ﬁrst approximation.
Ideally, the assumed mixture in such analyses
could be described by a complete multimedia
assessment of all potential sources of pesticide
exposure. In future studies, we plan to address
this issue by basing cumulative OP pesticide
dose equivalent estimates on chemical-speciﬁc
biologic monitoring data.
In this assessment, we assumed that 100%
of absorbed maternal OP pesticide dose is
expressed in urine as diethyl and dimethyl
phosphate metabolites. This assumption may
underestimate dose because some metabolites
will be excreted in other biologic media
besides urine (e.g., feces). Grifﬁn et al. (1999)
reported that, on average, 93% of adminis-
tered chlorpyrifos was excreted in urine as
dialkyl phosphate metabolites in five adult
volunteers. Although the kinetics of elimina-
tion vary among the dimethyl and diethyl
phosphate metabolites, toxicologic evidence
suggests that the metabolites of many OP
compounds are excreted primarily, but not
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Table 4. Method 2 estimated average cumulative OP pesticide dose equivalents
a (µg/kg/day) for 446 pregnant
women with chlorpyrifos as index chemical.
Dimethyls only Diethyls only Totalb
10th percentile 0.9 0.1 1.0
25th percentile 1.9 0.1 2.1
50th percentile 4.0 0.2 4.4
75th percentile 9.5 0.4 10.0
90th percentile 19.8 0.8 20.1
Geometric mean (95% CI) 4.1 (3.6–4.6) 0.2 (0.2–0.3) 4.5 (4.1–5.1)
Range 0.1–171.3 0.01–6.6 0.1–171.4
Estimates exceeding index chemical’s
BMD10/100 (%)c 63 (14.1) 0 (0) 66 (14.8)
aAverage cumulative dose equivalents were derived from metabolite levels measured in three urine samples. bTotal
dimethyl and diethyl OP pesticides. cBMD10/100 of index chemical (chlorpyrifos) = 14.8 µg/kg/day.
Figure 3. Distribution of average cumulative OP pesticide dose estimates for pregnant women in an agri-
cultural community (n = 446). UF, uncertainty factor. 
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Cumulative percentageexclusively, in the urine (Grifﬁn et al. 1999;
Krieger and Dinoff 2000). Further, total OP
pesticide exposure may be underestimated
because several OP pesticides, such as acephate,
do not metabolize to any of the urinary dialkyl
phosphate metabolites and are therefore not
included in our exposure–dose estimates.
These OP pesticides, which do not devolve
into dialkyl phosphate metabolites, represent
approximately 20% of total OP pesticide use
in the CHAMACOS study area.
A potentially large source of variability in
our models results from the urinary metabolite
data themselves. For these analyses we esti-
mated dose based on three spot urine samples
collected from each study participant over a 6-
month period. Thus, uncertainty due to
intraindividual variability and temporal varia-
tion in dialkyl phosphate metabolite levels was
introduced. To reduce this source of variabil-
ity in future studies, multiple urine samples
collected per day over several days are needed.
Furthermore, urine samples were collected at
various times throughout the day, at the con-
venience of the participants. The effect of this
source of variability is unknown, but it is
likely that both over- and underestimates of
actual daily doses were generated.
Adjusting metabolite concentration data
for total daily urine volume was necessary
because 24-hr urine samples are impractical in
community-based studies and were not col-
lected. Although creatinine adjustment is a
common interpretive step in biologic moni-
toring studies, its merits are debated in the
scientific community (Boeniger et al. 1993).
As a point of comparison, we also generated
dose estimates by adjusting for total daily
urine output volume based on reference val-
ues for pregnant women from the literature.
Cumulative dose estimates calculated from
volume-adjusted data were highly correlated
with creatinine-adjusted estimates (R2 = 0.8)
and did not substantively change our find-
ings. Because creatinine adjustments yielded
reasonable estimates for total daily urine vol-
umes, and they are expected to account for
the relative concentrations/dilutions of the
urine samples, we chose to report creatinine-
adjusted dose estimates only.
It is also possible that these urinary
metabolites represent exposure to the break-
down products of the parent compounds,
rather than exposure to the OP pesticides
themselves. If this were true, pesticide doses
would tend to be overestimated (Fenske et al.
2000). To date, we have found no data in the
literature to indicate that this is the case for the
dialkyl phosphate metabolites. In fact, the
breakdown products are probably too polar to
be effectively absorbed through the skin (Barr
et al. 2002), potentially eliminating dermal
absorption of the breakdown products as a
contributor to the observed urinary metabolite
concentrations. More research is needed on the
kinetics of elimination of these compounds.
Findings from one Japanese toxicologic study
suggest that exposure to diethyl phosphate
metabolites would predominately result in the
excretion of inorganic phosphate (Imaizumi et
al. 1993). When rats were orally exposed to the
diethyl phosphate metabolites DEP and DETP
at a dose of 1 g/kg, DETP intensely inhibited
cholinesterase in rat brain homogenate, and
DEP weakly inhibited the cholinesterase activ-
ity. DEP-treated rats excreted inorganic phos-
phate and organic phosphate in the 24-hr
urine at amounts of 53 and 13% of the dose,
respectively. DETP-treated animals excreted
inorganic phosphate and organic phosphate in
their urine at amounts of 18 and 10% of the
dose, respectively (Imaizumi et al. 1993).
Risk evaluation of cumulative exposures
would be improved by the development of
suitable regulatory reference doses. Possible
points of departure for cumulative risk assess-
ment of OP pesticides include the NOAEL
and BMD10. The U.S. EPA is reﬁning guide-
lines for formally considering standard uncer-
tainty factors and the FQPA safety factor in
cumulative risk assessments of chemicals shar-
ing a common mechanism of toxicity (U.S.
EPA 2002c). Following the general methodol-
ogy used to derive RfDs from NOAELs, we
have applied a 100-fold uncertainty factor to
the index chemical’s BMD10 to account for
intra- and interspecies variability. This health-
protective dose level may not be adequately
protective for this population of pregnant
women, and an additional FQPA safety factor
may be necessary to account for the special sen-
sitivity of the developing fetus to OP pesticide
exposure. The U.S. EPA has recently proposed
applying a 3× FQPA safety factor to the RPFs
for six of the eight pesticides in our cumulative
assessment group (U.S. EPA 2002d). When
these 3× safety factors are applied at the RPF
calculation stage (as proposed), the percentage
of CHAMACOS participants with cumulative
exposures exceeding the BMD10/100 increases
from 14.8 to 41.9%.
We expect the human fetus to be par-
ticularly sensitive to OP pesticide exposure
because during gestation the human brain
is growing and developing very rapidly.
Toxicologic studies have shown that OP
compounds can cross the placental and
blood–brain barriers (Chanda and Pope 1996;
Gupta et al. 1985; Muto et al. 1992). As part
of a prospective cohort study being conducted
by the Columbia Center for Children’s
Environmental Health, Whyatt et al. (2003)
analyzed 142 paired blood samples collected at
birth from minority mothers and newborns for
29 pesticides. They reported that 8 of the 29
pesticides (including diazinon and chlorpyrifos)
were detected in > 25% of the maternal and/or
cord blood samples. In another study, Whyatt
and Barr (2001) detected levels of dialkyl phos-
phate metabolites in meconium samples col-
lected from 20 newborn infants. These
ﬁndings suggest that OP pesticides are readily
transferred from the mother to the developing
human fetus (Perera et al. 2002).
For this assessment, we estimated absorbed
OP pesticide dose for pregnant women. To
calculate fetal dose, however, a better under-
standing of the physiologic and pharmacoki-
netic processes that would determine transfer
from the mother to fetus is required. Future
research is needed to explore the feasibility of
using physiologically based pharmacokinetic
modeling to reconstruct fetal dose from mater-
nal biologic monitoring data. Virtually no
data are available regarding the absorption,
metabolism, and excretion of OP pesticides in
pregnant women.
In conclusion, our results suggest that a
small portion of pregnant women participat-
ing in the CHAMACOS study may have
cumulative OP pesticide exposures exceeding
a health-protective reference value. The poten-
tial impact of these exposures to fetal health is
unknown.
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